Advertisement

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

United States
Advertisement
Advertisement
Advertisement

Diplomacy

Rubio swaps hawk for diplomat in year-end pivot on China

Top US envoy eschews ‘pacing threat’ label, stressing cooperation and Western hemisphere priorities for 2026.

Focus
Illustration: Henry Wong

From taboo to trendy: China’s second-hand luxury market cashes in on resale boom

Trump Justice Department releases partial set of Epstein files for now

US official says more of the long-awaited documents will follow in coming months, citing legal limits to protect victims and investigations.

Advertisement

The journey ahead: AI paves the way for tourism business of the future

AI travel technology company Dida’s innovative solutions aim to bridge the gap between the industry and travellers.

In partnership with:
Dida
Dida is collaborating with the tourism industry to respond to the challenges and opportunities that AI is bringing to the sector.
Advertisement
Advertisement
OPINION
Wee Kek Koon

Reflections | Malaysia’s unusual creation still affects it today. China mulled doing similar

Wee Kek Koon
SCMP Editorial
MORE COMMENT
LATEST

Video | Politics fails to dampen launch of Japanese sushi chain Sushiro in Shanghai

MORE LATEST NEWS
Advertisement
Advertisement
Advertisement
Advertisement
SCMP Series
WWII: 80 years on
China Inc. goes global
Chinese scientists return home
How China is telling its own story
SCMP SeriesWWII: 80 years on
Open Questions series
China Future Tech
China Future Tech
Key Industries:
Advertisement
Advertisement
Advertisement